Semaglutide (Wegovy ) Tablet (Commercial Product by Novo Nordisk) Semaglutide Injectable Description 1-3 Semaglutide, a synthetic glucagon-like peptide-1 receptor agonist (GLP-1 RA), is an incretin mimetic
Their tuneable optical properties, specific surface-engineering strategies, and favourable biocompatibility support a broad range of experimental uses, including intracellular imaging, simultaneous imaging and therapy, antiviral and antimicrobial strategies, and emerging neuroprotective applications
There have been case reports of psychiatric symptoms in people taking GLP-1 medications
This is not a rare occurrence
State-level enforcement has added a third layer, with several jurisdictions pursuing independent actions against wellness clinics and medical spas administering grey-market compounds without adequate physician oversight, none of it coordinated with federal action
Some researchers swear by it